Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Hepatic Insufficiency”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Early research (Phase 1)Study completedNCT00416702
What this trial is testing

Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function

Who this might be right for
Hepatic Insufficiency
Novartis 32
Early research (Phase 1)Study completedNCT04587622
What this trial is testing

Pharmacokinetic Study of Icenticaftor in Participants With Hepatic Impairment

Who this might be right for
Hepatic Failure
Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT02910739
What this trial is testing

An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 16
Not applicableStudy completedNCT04787276
What this trial is testing

Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyLiver CirrhosisEnd Stage Liver DIsease
Bogomolets National Medical University 42
Early research (Phase 1)Not Yet RecruitingNCT07055412
What this trial is testing

Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects

Who this might be right for
Pharmacokinetic DifferencesY-3Saftey+3 more
Neurodawn Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT05882032
What this trial is testing

LY3502970 in Participants With Impaired and Normal Liver Function

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 29
Not applicableStudy completedNCT04147936
What this trial is testing

Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency

Who this might be right for
Hepatic Insufficiency
Axcella Health, Inc 60
Early research (Phase 1)Study completedNCT01916993
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of a Single Dose of NBI-98854 in Subjects With Mild,Moderate, or Severe Hepatic Insufficiency

Who this might be right for
Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects
Neurocrine Biosciences 24
Early research (Phase 1)Study completedNCT04123769
What this trial is testing

Study on PK of Hydronidone in Patients and Special Population

Who this might be right for
Hepatitis b & Liver Dysfunction
Beijing Continent Pharmaceutical Co, Ltd. 8
Early research (Phase 1)Study completedNCT05098054
What this trial is testing

Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Takeda 36
Early research (Phase 1)Looking for participantsNCT07401862
What this trial is testing

Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

Who this might be right for
Hepatic Insufficiency
Eli Lilly and Company 36
Early research (Phase 1)Study completedNCT07049939
What this trial is testing

Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)

Who this might be right for
Hepatic Insufficiency
Merck Sharp & Dohme LLC 9
Early research (Phase 1)Study completedNCT05711797
What this trial is testing

Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects

Who this might be right for
Influenza, Human
Nanjing Zenshine Pharmaceuticals 16
Early research (Phase 1)UnknownNCT06176716
What this trial is testing

Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

Who this might be right for
Hepatic Insufficiency
Ahon Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Early research (Phase 1)Looking for participantsNCT07165002
What this trial is testing

The Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 32
Early research (Phase 1)Study completedNCT00805090
What this trial is testing

Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compared to Sporanox® in Healthy Subjects

Who this might be right for
Renal Insufficiency, ChronicHepatic InsufficiencyHealthy
Javelin Pharmaceuticals 37
Early research (Phase 1)Study completedNCT05185011
What this trial is testing

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

Who this might be right for
Erectile DysfunctionPulmonary Arterial Hypertension
Vigonvita Life Sciences 24
Not applicableWithdrawnNCT05131230
What this trial is testing

CytoSorb® in Patients With Acute on Chronic Liver Failure

Who this might be right for
Acute on Chronic Liver FailureAlcoholic Hepatitis
CytoSorbents Europe GmbH
Early research (Phase 1)Not Yet RecruitingNCT07550634
What this trial is testing

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

Who this might be right for
Hepatic Impairment (Mild and Moderate, Child-Pugh Class A and B)Hepatic Insufficiency (MeSH ID: D048550)
MindRank AI Ltd 32
Next Page